Abstract:Fibrin sealant is an effective haemostatic agent. The results obtained in our study show that the administration of fibrin sealant in patients receiving anticoagulant treatment eliminates postoperative haematomas after pacemaker implantation.
“…Topical fibrin sealants reduce hematoma formation in anti-coagulated patients undergoing device procedures, but their effect on DRI is unknown. 79 Cephalic cut down has theoretical advantages in reducing post-operative bleeding by avoiding inadvertent arterial puncture. 80 In the event of failed cephalic access or when additional venous access is required ultrasound guided vascular access may also reduce the risk of arterial puncture.…”
“…Topical fibrin sealants reduce hematoma formation in anti-coagulated patients undergoing device procedures, but their effect on DRI is unknown. 79 Cephalic cut down has theoretical advantages in reducing post-operative bleeding by avoiding inadvertent arterial puncture. 80 In the event of failed cephalic access or when additional venous access is required ultrasound guided vascular access may also reduce the risk of arterial puncture.…”
“…12,13 Alternatively, fibrin sealant has been proposed as a useful agent to reduce risk of hematoma. 14 In any case, aggressive management with compression will minimize the risk of wound dehiscence. It is advisable only in the rare cases in which closure line integrity is threatened to surgically evacuate a hematoma, because opening the pocket at that juncture greatly increases the subsequent risk of infection.…”
Background-Device implant pocket hematoma is a recognized complication after permanent pacemaker (PM) and implantable cardioverter-defibrillator (ICD) implantation. Pocket hematoma is associated with local discomfort, an increased risk of infection, and may require surgical intervention or lead to lengthier hospital stays. The purpose of the study was to identify the clinical factors associated with hematoma formation after PM or ICD device implantation.
Methods and Results-The
“…Although this increase was not statistically significant, the use of D-Stat Flowable was prematurely stopped by our institutional clinical event committee during a planned interims analysis. The reason for this somewhat unexpected observation is unclear, previous studies reported no infectious complications [15], or only report on "pocket related complications" in general without providing results for infectious complications [11]. However, research focused on the addition of antibiotics to hemostats in order to provide local antimicrobial effect during tissue healing was performed in the late 1980s and early 1990s.…”
Section: Pocket Infection and Local Haemostat Usementioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.